Institutional investors purchased a net $5.5 million shares of NVO during the quarter ended December 2017 and now own 8.34% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELCH & FORBES LLC Bought 9.5 Thousand shares of Novo Nordisk A/S
KERNS CAPITAL MANAGEMENT, INC. Bought 4.9 Thousand shares of Novo Nordisk A/S
GRADIENT INVESTMENTS LLC Bought 3.7 Thousand shares of Novo Nordisk A/S